Relationship between PCO2 and unfavorable outcome in infants with moderate-to-severe hypoxic ischemic encephalopathy

Krithika Lingappan1, Jeffrey R Kaiser2, Chandra Srinivasan3

  • 1Department of Pediatrics (Neonatology), Baylor College of Medicine, Houston, Texas.

Pediatric Research
|April 7, 2016
PubMed

Insights

Low carbon dioxide levels (hypocapnia) in infants with hypoxic ischemic encephalopathy (HIE) are linked to poor outcomes. This study found hypocapnia independently predicts death or disability in HIE patients.

Area of Science:

  • Neonatal neurology
  • Pediatric critical care
  • Neurodevelopmental outcomes

Background:

  • Abnormal partial pressure of carbon dioxide (PCO2) is frequent in infants diagnosed with hypoxic ischemic encephalopathy (HIE).
  • Investigating the link between hypocapnia and adverse outcomes in HIE is crucial for understanding disease progression.

Purpose of the Study:

  • To determine if hypocapnia is an independent predictor of unfavorable outcomes in infants with moderate-to-severe HIE.
  • To analyze the association between PCO2 levels and neurodevelopmental outcomes at 18 months post-birth.

Main Methods:

  • A post hoc analysis of the CoolCap Study data was conducted.
  • Blood gas data (PCO2) and follow-up information were analyzed for 196 infants.
  • Statistical models adjusted for factors including pH, EEG background, seizures, birth weight, Apgar score, cooling status, and Sarnat stage.

Main Results:

  • After adjusting for key clinical variables, PCO2 showed a significant inverse association with unfavorable outcomes (P < 0.001).
  • The probability of unfavorable outcomes increased substantially as PCO2 decreased, with higher risks observed in severe HIE cases.
  • Specifically, PCO2 levels of 40, 30, and 20 mm Hg corresponded to estimated unfavorable outcome probabilities of 0.20, 0.53, and 0.89, respectively.

Conclusions:

  • Hypocapnia in infants with moderate-to-severe HIE is independently associated with an increased risk of unfavorable outcomes.
  • These findings highlight the importance of monitoring and potentially managing PCO2 levels in HIE.
  • Future research should explore the efficacy of interventions aimed at controlled normocapnia in this vulnerable population.
Abstract

Related Concept Videos

Acute Respiratory Failure-III01:30

Acute Respiratory Failure-III

Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without...
1.1K
Diagnosing Acidosis and Alkalosis01:24

Diagnosing Acidosis and Alkalosis

Diagnosing acid-base imbalances involves systematically analyzing arterial blood samples, focusing on three key measurements: pH, bicarbonate (HCO3−) concentration, and carbon dioxide partial pressure (PCO2). This analysis follows a four-step process that helps identify the imbalance's underlying cause and nature.
First, the pH level is assessed to determine whether the blood pH is normal (7.35–7.45), low (acidosis), or high (alkalosis).
Next, the PCO2  and...
1.6K
Assessment of Diffusion and Perfusion01:17

Assessment of Diffusion and Perfusion

Understanding and evaluating diffusion and perfusion is critical in assessing a patient's respiratory and circulatory health. These processes play key roles in maintaining the body's internal environment, ensuring that tissues receive adequate oxygen while waste products are efficiently removed.
The Role of Diffusion in Respiration
Diffusion is the process by which molecules move from an area of higher concentration to an area of lower concentration. In the respiratory system, this...
2.0K
Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
1.5K
Oxygen Transport in the Blood01:27

Oxygen Transport in the Blood

Hemoglobin (Hb) is a crucial molecule in the human body, consisting of four polypeptide chains, each bound to an iron-containing heme group. This unique structure enables hemoglobin to bind to oxygen, with each molecule capable of combining with four molecules of oxygen, leading to rapid and reversible oxygen loading. When fully loaded with oxygen, it is called oxyhemoglobin, while hemoglobin that has released oxygen is called reduced hemoglobin or deoxyhemoglobin. As hemoglobin binds oxygen,...
8.1K
Acute Respiratory Failure-I01:21

Acute Respiratory Failure-I

Acute respiratory failure is a condition characterized by the inability of the lungs to perform their primary function: gas exchange. This failure leads to insufficient oxygen levels (hypoxemia) in the blood, elevated carbon dioxide levels (hypercapnia), or both, causing critical impairment in organ function.
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
1.4K